Bacillus Calmette-Guérin vaccination, thymic size, and thymic output in healthy newborns

Nina Marie Birk1, Thomas Nørrelykke Nissen1, Vera Zingmark1

  • 1Department of Pediatrics, Copenhagen University Hospital, Hvidovre, Denmark.

Pediatric Research
|February 4, 2017
PubMed

Insights

Bacillus Calmette-Guérin (BCG) vaccination at birth did not alter thymic size. However, larger thymic size at birth correlated with more lymphocytes and fewer infections in infants.

Area of Science:

  • Immunology
  • Pediatrics
  • Vaccinology

Background:

  • The Bacillus Calmette-Guérin (BCG) vaccine is known for potential nonspecific benefits in infant health.
  • Investigating BCG's impact on thymic size and its relation to immune function is crucial for understanding early-life immunity.

Purpose of the Study:

  • To determine if BCG vaccination at birth affects thymic size in infants.
  • To explore associations between thymic size, thymic output, lymphocyte counts, infection risk, and BCG vaccination.

Main Methods:

  • Infants were randomized to receive BCG vaccination or no vaccination.
  • Thymic index (TI) and thymic/weight index (TWI) were measured via ultrasound at birth and 3 months.
  • T cell subpopulations (CD4+, CD8+, recent thymic emigrants) were analyzed using flow cytometry; infections were parent-reported.

Main Results:

  • BCG vaccination did not significantly impact thymic size (TI) at 3 months.
  • At birth, higher lymphocyte counts (including CD4+, CD8+, and recent thymic emigrants) were associated with larger thymic size (TI and TWI).
  • A larger thymic size at birth was linked to a reduced risk of infections within the first 3 months of life.

Conclusions:

  • BCG vaccination showed no discernible effect on thymic size.
  • Thymic size, assessed by TI and TWI, may serve as a predictor of an infant's immunological capacity.
  • The findings highlight the importance of thymic size in relation to lymphocyte production and protection against early-life infections.
Abstract